Stay updated on Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Locations section expanded to include US states and Canadian provinces, listing numerous sites; page revision updated to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T20:43:19.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Added that PubMed-derived publications are automatically filled and the page revision is updated to v3.3.2, while removing the older PubMed description and revision v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T10:44:03.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The government funding lapse notice on the page has been removed; this does not affect core study information or enrollment details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-18T06:55:36.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The Taiwan site entry was updated from 'Tainan City, Taiwan' to 'Tainan, Taiwan' in the Locations section.
    Difference
    0.0%
    Check dated 2025-11-11T02:18:13.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The new screenshot shows the same ClinicalTrials.gov study page as the previous one, with no additions or deletions of core content (arms, outcomes, locations, enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T20:56:28.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    New operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.
    Difference
    2%
    Check dated 2025-10-06T05:22:02.000Z thumbnail image

Stay in the know with updates to Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial page.